STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2190 by analyst upside · 2026-08-13
SNY
Sanofi
Healthcare · Market Cap $105B · P/E 23.2x
ANALYST PRICE TARGET
+22.9%
implied upside to consensus target
Current Price $43.71
Consensus Target $53.72
Bull Target $63.0
Bear Target $45.0
Analysts Covering 9
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
4
Hold
4
Sell
1
52-Week Low $40.89
52-Week High $52.68
YTD Return -4.3%
FUNDAMENTALS
Market Cap $105B
P/E Ratio (TTM) 23.2x
Forward P/E 8.2x
EPS (TTM) $1.88
PEG Ratio 28.53
Dividend Yield 5.55%
Revenue (TTM) $48.9B
Profit Margin 8.1%
52-WEEK RANGE
52-Week Low $40.89
52-Week High $52.68
Current Price $43.71
Bear Target $45.0
Bull Target $63.0
● Now $43.71 ● Target $53.72
TRADING DATA
Avg Volume 3.4M
YTD Return -4.3%
Analyst Count 9
Consensus Hold
Upside to Target +22.9%
Last Updated 2026-08-13

ANALYST SUMMARY

Sanofi (SNY) is currently trading at $43.71 with a Wall Street consensus price target of $53.72, implying potential upside of 22.9% over the next 12 months. 9 analysts currently cover SNY, with a consensus rating of Hold - 44% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $63.0, while the most cautious has a target of $45.0.

SNY operates in the Healthcare sector with a market capitalisation of $105B. The stock is down 4.3% year-to-date and is currently trading near the lower end of its 52-week range of $40.89 – $52.68.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SNY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS ↓ Downgrade
Buy → Neutral 2026-01-16 33% win rate (6 calls)
Barclays ↓ Downgrade
Overweight → Equal-Weight 2026-01-06 Building track record
Guggenheim ↓ Downgrade
Buy → Neutral 2025-12-09 62% win rate (8 calls)
JP Morgan ↓ Downgrade
Overweight → Neutral 2025-12-08 43% win rate (7 calls)
Morgan Stanley ↑ Upgrade
Equal-Weight → Overweight 2025-09-08 Building track record
Deutsche Bank ↑ Upgrade
Hold → Buy 2025-09-02 Building track record
JP Morgan ↑ Upgrade
Neutral → Overweight 2025-08-08 43% win rate (7 calls)
Goldman Sachs ● Initiated
Neutral 2025-03-21 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
47
out of 100
Coverage depth
18/30
Consensus clarity
22/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →